Advertisement
American Association of Endocrine Surgeons| Volume 128, ISSUE 6, P999-1006, December 2000

Download started.

Ok

A murine model of allogeneic adrenocortical cell transplantation: Perspectives for the treatment of Addison's disease in humans

      Abstract

      Background. Hormone substitution for the treatment of adrenocortical insufficiency (Addison's disease) does not adequately substitute the hormone peaks required in stress situations. Therefore, allogeneic transplantation of adrenal cortex could offer an intriguing alternative. Methods. Major histocompatibility complex (MHC) class I transgenic mice were used for the implementation of an animal model of adrenocortical cell transplantation in adrenalectomized mice. Kb-transgenic cells and allogeneic adrenocortical cells were cocultured in mixed lymphocyte cultures to examine the alloimmune response. Lymphocytes from T-cell receptor transgenic mice and normal allogeneic mice served as responder cells. The effect of corticosteroids secreted by adrenocortical cells was antagonized by the steroid receptor antagonist mifepristone (RU486). Results. In vitro coculture experiments showed that MHC class I disparate adrenocortical cells failed to activate B10.BR and T-cell receptor transgenic lymph node cells. In the presence of mifepristone this inhibitory effect was antagonized, resulting in strong lymphocyte proliferation. Activation of B10.BR lymphocytes by Kb-disparate spleen cells was also abolished in the presence of adrenocortical cells. This effect, however, could not be reversed by mifepristone. Conclusions. In vitro, the presence of adrenocortical cells potently suppressed allogeneic immune responses. This effect was only in part due to the secretion of corticosteroids, pointing to an additional immunomodulatory property of adrenocortical cells. (Surgery 2000;128:999-1006.)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Willis AC
        • Vince FP
        The prevalence of Addison's disease in Coventry, UK.
        Postgrad Med J. 1997; 73: 286-288
        • Kong MF
        • Jeffcoate W
        Eighty-six cases of Addison's disease [comments].
        Clin Endocrinol (Oxf). 1994; 41: 757-761
        • Becker KL
        • Loriaux DL
        Principles and practice of endocrinology and metabolism.
        in: Library of Congress cataloging-in-publications-data. : JB Lippincot Company, Philadelphia1990
        • Zelissen PM
        • Croughs RJ
        • van Rijk PP
        • Raymakers JA
        Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison disease [comments].
        Ann Intern Med. 1994; 120: 207-210
        • Seeliger H
        • Hoffmann MW
        • Tschernig T
        • Philippens KMH
        • Schürmeyer TH
        • Scheumann GFW
        Transplantation of H-2Kb-transgenic adrenocortical cells in the adrenalectomized mouse: functional and morphological aspects.
        Transplantation. 2000; 69: 1561-1566
        • Zacharchuk CM
        • Mercep M
        • Chakraborti PK
        • Simons Jr, SS
        • Ashwell JD
        Programmed T lymphocyte death: cell activation-and steroid-induced pathways are mutually antagonistic.
        J Immunol. 1990; 145: 4037-4045
        • Wiegers GJ
        • Croiset G
        • Reul JM
        • Holsboer F
        • de Kloet ER
        Differential effects of corticosteroids on rat peripheral blood T-lymphocyte mitogenesis in vivo and in vitro.
        Am J Physiol. 1993; 265: E825-E830
        • Stites DP
        • Siiteri PK
        Steroids as immunosuppressants in pregnancy.
        Immunol Rev. 1983; 75: 117-138
        • Lazar G
        • Agarwal MK
        Physiological action and receptor binding of a newly synthesized and novel antiglucocorticoid.
        Biochem Biophys Res Commun. 1986; 134: 44-50
        • Emilie D
        • Galanaud P
        • Baulieu EE
        • Dormont J
        Inhibition of in vitro immunosuppressive effects of glucocorticosteroids by a competitive antagonist RU-486.
        Immunol Lett. 1984; 8: 183-186
        • Duval D
        • Durant S
        • Homo-Delarche F
        Effect of antiglucocorticoids on dexamethasone-induced inhibition of uridine incorporation and cell lysis in isolated mouse thymocytes.
        J Steroid Biochem. 1984; 20: 283-287
        • Heath WR
        • Kjer Nielsen L
        • Hoffmann MW
        Avidity for antigen can influence the helper dependence of CD8+ T lymphocytes.
        J Immunol. 1993; 151: 5993-6001
        • Schönrich G
        • Kalinke U
        • Momburg F
        • et al.
        Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction.
        Cell. 1991; 65: 293-304
        • Scheumann GF
        • Hiller WF
        • Schröder S
        • Schürmeyer T
        • Klempnauer J
        • Dralle H
        Adrenal cortex transplantation after bilateral total adrenalectomy in the rat.
        Henry Ford Hosp Med J. 1989; 37: 154-156
        • Hiller WF
        • Steiniger B
        • Klempnauer J
        The role of histocompatibility antigens in transplantation of isolated islets of Langerhans in the rat.
        Diabetes. 1993; 42: 90-97
        • Morrow CE
        • Sutherland DER
        • Steffes MW
        • Najarian JS
        • Bach FH
        H-2 antigen class: effect on mouse islet allograft rejection.
        Science. 1983; 219: 1337-1339
        • Kneteman NM
        • Halloran PF
        • Sanden WD
        • Wang T
        • Seelis RE
        Major histocompatibility complex antigens and murine islet allograft survival.
        Transplantation. 1991; 51: 247-251
        • Ramrakha PS
        • Sharp RJ
        • Yeoman H
        • Stanley MA
        The influence of MHC-compatible and MHC-incompatible antigen-presenting cells on the survival of MHC-compatible cultured murine keratinocyte allografts.
        Transplantation. 1989; 48: 676-680
        • Aubock J
        • Irschick E
        • Romani N
        • et al.
        Rejection, after a slightly prolonged survival time, of Langerhans cell-free allogeneic cultured epidermis used for wound coverage in humans.
        Transplantation. 1988; 45: 730-737
        • Terasaka R
        • Lacy PE
        • Hauptfeld V
        • Bucy RP
        • Davie JM
        The effect of cyclosporin-A, low-temperature culture, and anti-Ia antibodies on prevention of rejection of rat islet allografts.
        Diabetes. 1986; 35: 83-88
        • Moser M
        • De Smedt T
        • Sornasse T
        • et al.
        Glucocorticoids down-regulate dendritic cell function in vitro and in vivo.
        Eur J Immunol. 1995; 25: 1218-1224
        • Van Voorhis BJ
        • Anderson DJ
        • Hill JA
        The effects of RU 486 on immune function and steroid-induced immunosuppression in vitro.
        J Clin Endocrinol Metab. 1989; 69: 1195-1199
        • Boumpas DT
        • Paliogianni F
        • Anastassiou ED
        • Balow JE
        Glucocorticosteroid action on the immune system: molecular and cellular aspects.
        Clin Exp Rheumatol. 1991; 9: 413-423
        • Paliogianni F
        • Ahuja SS
        • Balow JP
        • Balow JE
        • Boumpas DT
        Novel mechanism of inhibition of human T cells by glucocorticoids.
        J Immunol. 1993; 151: 4081-4089
        • Vacca A
        • Felli MP
        • Farina AR
        • Martinotti S
        • Maroder M
        • Screpanti I
        • et al.
        Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements.
        J Exp Med. 1992; 175: 637-646